Therefore, in terms of regulating the tumor microenvironment, ADRB2, SMAD4, FCER2 and PDCD1 had vital predictive significance in the immunotherapy of NSCLC. This evidence concerns the gene ADRB2 and non-small cell lung carcinoma.